Cognition Therapeutics, Inc.
Biotechnology ResearchNew York, United States11-50 Employees
Cognition Therapeutics, Inc. is a clinical stage neuroscience company developing drugs that help restore normal cellular damage responses in neurodegenerative and neuro-ophthalmic disorders.